Adoption of PROs in Early Clinical Trials for Oncology Drugs: Challenges and Opportunities Poster Adoption of PROs in Early Clinical Trials for Oncology Drugs: Challenges and Opportunities Despite changes in regulatory expectations, adoption of PROs in early-phase oncology trials remains very low…CertaraSeptember 20, 2023
PBPK Application in Drug Discovery and Development Poster PBPK Application in Drug Discovery and Development Real-World Application of Physiologically Based Pharmacokinetic Modeling (PBPK) in Support of Decision-Making During Drug Discovery;…CertaraSeptember 20, 2023
Top Lessons Learned from 300 Regulatory Submissions Blog Top Lessons Learned from 300 Regulatory Submissions Who would have thought when we completed work on the first submission for which we…CertaraSeptember 20, 2023
Certara launches Phoenix Hosted, a cloud-based solution of Phoenix™ software Announcement Certara launches Phoenix Hosted, a cloud-based solution of Phoenix™ software Certara launches Phoenix Hosted, a cloud-based solution of Phoenix™ software PRINCETON, N.J.— September 19, 2023…CertaraSeptember 19, 2023
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software Press Release Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelines. PRINCETON, NJ –…CertaraSeptember 19, 2023
Simcyp® Biopharmaceutics Factsheet Fact Sheet Simcyp® Biopharmaceutics Factsheet Elevating ‘Gold Standard’ PBPK Technologies for Biopharmaceutics, Drug Formulation, and CMC ExpertsCertaraSeptember 18, 2023
What is ICER & How Does it Impact the Pharmaceutical Industry? Blog What is ICER & How Does it Impact the Pharmaceutical Industry? The Institute for Clinical and Economic Review (ICER) is a US Health Technology Assessment organization.…CertaraSeptember 15, 2023
Modelling of the in vitro Biokinetics of Tebufenpyrad for in vivo Dose Estimation Poster Modelling of the in vitro Biokinetics of Tebufenpyrad for in vivo Dose Estimation CertaraSeptember 14, 2023
Pharma Focus America: Big Data Analytics – A Revolution in the Pharmaceutical Industry Press Coverage Pharma Focus America: Big Data Analytics – A Revolution in the Pharmaceutical Industry In this panel discussion, our panelists will explore how big data analytics is reshaping drug…CertaraSeptember 11, 2023
Methods to Increase Signal Finding in Rare Disease Drug Development Blog Methods to Increase Signal Finding in Rare Disease Drug Development The regulatory landscape for drugs to treat rare diseases is being disrupted. Gleaning from several…CertaraSeptember 8, 2023